戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 R (ASqPCR) for the KIT D816V mutation, and a bone marrow examination.
2             Fifty-three children underwent a bone marrow examination.
3 apy in CML and results in the need for fewer bone marrow examinations.
4  sepsis, her counts recovered by day 32, and bone marrow examination 6 weeks after diagnosis showed a
5 is is advised in patients who have undergone bone marrow examination and have an otherwise-unexplaine
6 mic patients are generally iron deficient on bone marrow examination, and after intravenous iron ther
7 e diagnostic SBP tissue or the corresponding bone marrow examination at the time of diagnosis, is ass
8                                              Bone marrow examination can reveal viral inclusions and
9                                              Bone marrow examinations demonstrated increased marrow c
10                 We recommend refraining from bone marrow examinations in suspected patients without U
11                                              Bone marrow examination indicated severely impaired B ce
12 only bacterial infection of humans for which bone marrow examination is routinely recommended.
13 nts with skin involvement who did not have a bone marrow examination (n = 188) were defined as having
14 her the diagnostic SBP tissue or the staging bone marrow examination of patients with newly diagnosed
15                                              Bone marrow examination revealed 90% infiltration with m
16                                              Bone marrow examination revealed a marked reduction in m
17                                              Bone marrow examination should be an essential part of t
18                                              Bone marrow examination showed hypoplastic bone marrow w
19            The CHr in 78 patients undergoing bone marrow examination was measured to assess its clini
20 Clinical history along with blood values and bone marrow examination were analyzed.
21                                Post-baseline bone-marrow examinations were done in 40 (63%) patients
22       We also anticipate that fewer invasive bone marrow examinations will be required, as these meth